The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
The grant will fund a collaboration investigating whether genomic signatures and other biomarkers can be used in clinical diagnosis and monitoring of kidney cancer.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
The Alabama Genomic Health Initiative aims to recruit participants from every county in the state and provide genomic analysis and interpretation free of charge.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
The agency has awarded five-year grants to three research institutions to promote education in genomic medicine among physicians and biomedical scientists.
Genome-wide association and other genetic studies hint at variants increasing subsequent neoplasm risk in individuals treated for cancer during childhood.
Their clinical trial will compare the effectiveness of tissue biopsies and liquid biopsies for tumor detection and monitoring.
A partnership with the Foundation for Mitochondrial Medicine and Seahorse Bioscience, the clinical program will evaluate Seahorse's XF Technology.
A University of Alabama, Birmingham team used the Illumina MiSeq platform to perform next-generation sequencing on 15 strains of M. pneumoniae.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.